Best Practices' Medical Affairs Consortium is delving deeper into the many challenges that leaders are facing throughout the Pharma, Biotech, and Medical Device companies. For more information, view our website: http://www.best-in-class.com/medical-affairs-consortium
Thank you for your time today. During our call I would like to share some recent data and insights from your peers in Medical Affairs. As you can see we work with many pharmaceutical organizations focusing on the challenges that they face. There are several core areas that we address including Medical Affairs.
The Medical Affairs Consortium will help Medical Affairs Leaders by answering 3 key questions:
1. How can we structure for success
2. How do we navigating through compliance
3. What are the best ways to Demonstrate our value to the Business
Here is a brief overview of our Project Methodology. A client will come to us with a particular challenge, in this case, how to develop a best-in-class Medical Affairs Function. We partner with our client to help them articulate the key business issue that they are facing, develop a survey instrument to gather data, connect the client with a peer benchmark group and lastly, analyze the data and provide key recommendations to move forward.
Here is a brief overview of our Project Methodology. A client will come to us with a particular challenge, in this case, how to develop a best-in-class Medical Affairs Function. We partner with our client to help them articulate the key business issue that they are facing, develop a survey instrument to gather data, connect the client with a peer benchmark group and lastly, analyze the data and provide key recommendations to move forward.
Conventional: The conventional Approach has been to grow with the organization and leadership. Traditionally, companies start with a focus on setting up to be a support function without thinking about the Value they can deliver to the organization. Many of our partners stated that they have a medical affairs organization in place because âthe corporation says we need one, so we have oneâ
The chart on this page illustrates the traditional stages/evolution that Medical Affairs Functions go through. If youâre just growing with the organization, then you will eventually hit a ceiling in terms of resources, investments, and the ability to drive value. Itâs only a matter of time before your investments will be challenged as products mature.
Through our survey and conversations with over 50 Medical Affairs Leaders, we identified several key challenges that they are facing:
-How to structure the function for success,
-Navigating through ever-changing regulatory requirements,
- Moving from a support only function to a Strategic Partner,
Ultimately this about how the Medical Affairs Function delivers and communicates value to the Business.
Most organizations begin with gaining support from Senior Leadership and therefore getting adequate resources, but as you can see there are many other Critical Success factors that Medical Affairs Leaders need to be focusing on. This is the pathway to developing a successful and valuable function â as identified by your peers.
The Medical Affairs Consortium will give you access to:
-Our Medical Affairs Database
-Participation in and access to ongoing support on Medical Affairs Excellence which will include guiding the survey questions
-Quarterly Webinars by our Advisors as well as peer Medical Affairs Leaders from leading companies
-Customized âHealthâ Check within Each Report â see where you stand across the benchmark
-Access to Best Practices Research Advisors â call on our Advisors to understand how others are using the data and insights from the research
-Monthly Newsletter collecting key Insights from our research
Thank you for your time today. During our call I would like to share some recent data and insights from your peers in Medical Affairs. As you can see we work with many pharmaceutical organizations focusing on the challenges that they face. There are several core areas that we address including Medical Affairs.